Using FDA-approved therapies like tirzepatide and semaglutide with close medical supervision, patients achieve meaningful, sustained weight loss and improved metabolic health
Long-term survival after low-dose-rate brachytherapy for prostate cancer: the Royal Surrey experience
Many people notice: Nausea or queasiness, especially early on Constipation or diarrhoea A noticeable drop in appetite, sometimes leading to rapid weight loss For most, these settle as the body adjusts, but the severity varies
Whether it shows up as icy hands, all-day chills, or a sudden drop in body warmth post-injection, the sensation is clearly real - and for some, unsettling
During hospitalization, no causes other than the medication were identified, and a liver biopsy confirmed the diagnosis of drug-induced cholestatic hepatitis
All statistical analyses were conducted using TriNetX built-in functions and R software (version 4.4.0)